
Piperaquine tetraphosphate tetrahydrate
CAS No. 915967-82-7
Piperaquine tetraphosphate tetrahydrate( —— )
Catalog No. M21000 CAS No. 915967-82-7
Piperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 42 | Get Quote |
![]() ![]() |
10MG | 65 | Get Quote |
![]() ![]() |
25MG | 132 | Get Quote |
![]() ![]() |
50MG | 205 | Get Quote |
![]() ![]() |
100MG | 309 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePiperaquine tetraphosphate tetrahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent.
-
DescriptionPiperaquine tetraphosphate tetrahydrate is a potent anti-parasites agent.(In Vivo):Piperaquine (10-90 mg/kg; a single i.p.) decreases parasitemia at all of the doses tested in mice.Piperaquine (90 mg/kg; a single i.p.) exhibits the t1/2, apparent clearance, and apparent volume of distribution 17.8 days, 33.5 mg?h/L, 1.55 L/h/kg, and 956 L/kg, respectively, in healthy mice and 16.1 days, 27.3 mg?h/L, 1.9 L/h/kg, and 1,059 L/kg in malaria-infected mice.
-
In Vitro——
-
In VivoPiperaquine (10-90 mg/kg; a single i.p.) decreases parasitemia at all of the doses tested in mice.Piperaquine (90 mg/kg; a single i.p.) exhibits the t1/2, apparent clearance, and apparent volume of distribution 17.8 days, 33.5 mg?h/L, 1.55 L/h/kg, and 956 L/kg, respectively, in healthy mice and 16.1 days, 27.3 mg?h/L, 1.9 L/h/kg, and 1,059 L/kg in malaria-infected mice. Animal Model:Male BALB/c mice (7 to 8 weeks) are inoculated with Plasmodium berghei parasites Dosage:0, 10, 30, 90 mg/kg Administration:A single i.p. administration Result:The median survival time was 10 days at dose of 10 mg/kg.The median survival time was 54 days at dose of 30 mg/kg.All mice were active and alert and had stable body weights throughout the course of the study at dose of 90 mg/kg.Animal Model:Male Swiss mice (6 weeks old)Dosage:90 mg/kg (Pharmacokinetic Analysis)Administration:A single i.p. administration Result:t1/2=17.8 d; AUC=33.5 mg?h/L; apparent clearance=1.55 L/h/kg; apparent volume of distribution=956 L/kg.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptorParasite
-
Research AreaInfection
-
IndicationUncomplicated Plasmodium Falciparum Malaria
Chemical Information
-
CAS Number915967-82-7
-
Formula Weight999.6
-
Molecular FormulaC29H32Cl2N6.4H3O4P.4H2O
-
Purity>98% (HPLC)
-
SolubilityH2O:6 mg/mL (6.00 mM; Need ultrasonic)
-
SMILESClc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1.O.O.O.O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fivelman Q L Adagu I S Warhurst D C . Effects of Piperaquine Chloroquine and Amodiaquine on Drug Uptake and of These in Combination with Dihydroartemisinin against Drug-Sensitive and -Resistant Plasmodium falciparum Strains[J]. Antimicrobial Agents and Chemotherapy 2007 51(6):2265-2267.
molnova catalog



related products
-
DNDI-6148
DNDI-6148 has anti-experimental cutaneous leishmaniasis activity and can be used to study visceral leishmaniasis by inhibiting Leishmania protozoa cleavage and polyadenylation-specific factor (CPSF3) endonuclease.
-
FR900098 sodium salt
FR 900098 is a derivative of fosmidomycin that inhibits DOXP reductoisomerase, demonstrates antimalarial activity with IC50 of 170, 170, and 90 nM for HB3, A2, and Dd2 P. falciparum strains, respectively.
-
Rufigallol
Rufigallol (AI3-00865) is an electron-deficient disk-shaped molecule with six hydroxyl groups and is a good unit for inducing the formation of DLC from non-planar AIE molecules, an anthraquinone derivative.